Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "G03GA" (68)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Chorionic Gonadotrophin (G03GA01) 7 products
WHO-DDD
DrugBank.ca
IP
CI
Choriomon 5'000
Durchstechflasche(n)
PR
PR
k.A.
preparazione iniettabile (fiala con solvente): Gonadotrophinum Chorionicum 5000 UI
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Choriomon 5'000
3 Durchstechflasche(n)
PR
PR
k.A.
preparazione iniettabile (fiala con solvente): Gonadotrophinum Chorionicum 5000 UI
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Choriomon 5'000
10 Durchstechflasche(n)
PR
PR
k.A.
preparazione iniettabile (fiala con solvente): Gonadotrophinum Chorionicum 5000 UI
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Choriomon 1000
3 Durchstechflasche(n)
6.47
16.25
k.A.
preparazione iniettabile (siringa preriempita con solvente): Gonadotrophinum Chorionicum 1000 UI
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Choriomon 2000
3 Durchstechflasche(n)
8.17
25.30
k.A.
preparazione iniettabile (siringa preriempita con solvente): Gonadotrophinum Chorionicum 2000 UI
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Choriomon 5000
Durchstechflasche(n)
PR
PR
k.A.
preparazione iniettabile (siringa preriempita con solvente): Gonadotrophinum Chorionicum 5000 UI
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Choriomon 5000
3 Durchstechflasche(n)
PR
PR
k.A.
preparazione iniettabile (siringa preriempita con solvente): Gonadotrophinum Chorionicum 5000 UI
IBSA Institut
Biochimique SA
B
FB
G
Human Menopausal Gonadotrophin (G03GA02) 18 products
WHO-DDD
DrugBank.ca
L
IP
CI
Merional HG 75 I.U.
Durchstechflasche(n)
23.80
42.30
10 %
Injection preparation: Menotropinum 75 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Merional HG 75 I.U.
10 Durchstechflasche(n)
190.40
223.50
10 %
Injection preparation: Menotropinum 75 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Merional HG 150 I.U.
Durchstechflasche(n)
40.95
60.95
10 %
Injection preparation: Menotropinum 150 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Merional HG 150 I.U.
10 Durchstechflasche(n)
327.60
372.70
10 %
Injection preparation: Menotropinum 150 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Menopur
10 ampoule(s)
201.74
235.80
10 %
Lyophilisate and solvent: Menotropinum 75 UI
Ferring AG
A / SL
FB
G
L
IP
CI
Menopur Multidose 600
I.U.
1 +
160.72
191.20
10 %
Lyophilisate and solvent: Menotropinum 600 UI
Ferring AG
A / SL
FB
G
L
IP
CI
Menopur Multidose Pen 600 IU
160.72
191.20
10 %
Injektionslösung im Fertigpen: Menotropinum 600U.I. / 0.96ml
Ferring AG
A / SL
FB
G
L
IP
CI
Merional HG 900 I.E.
Multidose
1 +
196.56
230.20
10 %
polvere e soluzione per soluzione iniettabile: Menotropinum 900 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
IP
CI
Merional 75 U.I.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: 2 Active Agents
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional 75 U.I.
10 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: 2 Active Agents
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional 150 U.I.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: 2 Active Agents
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional 150 U.I.
10 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: 2 Active Agents
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional HG 75 I.U.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Menotropinum 75 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional HG 75 I.U.
10 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Menotropinum 75 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional HG 150 I.U.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Menotropinum 150 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Merional HG 150 I.U.
10 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Menotropinum 150 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Menopur Multidose 1200
I.U.
1 + 2
PR
PR
k.A.
Lyophilisate and solvent: Menotropinum 1200 UI
Ferring AG
A
FB
G
IP
Menopur Multidose Pen
1200 IU
PR
PR
k.A.
Injektionslösung im Fertigpen: Menotropinum 1200U.I. / 1.92ml
Ferring AG
A
FB
G
Urofollitropin (G03GA04) 16 products
WHO-DDD
DrugBank.ca
L
IP
CI
Fostimon 75 U.I.
Durchstechflasche(n)
25.15
43.75
10 %
Injection preparation: Urofollitropinum 75 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Fostimon 75 U.I.
10 Durchstechflasche(n)
248.96
287.15
10 %
Injection preparation: Urofollitropinum 75 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Fostimon 150 U.I.
Durchstechflasche(n)
43.54
63.75
10 %
Injection preparation: Urofollitropinum 150 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
L
IP
CI
Fostimon 150 U.I.
10 Durchstechflasche(n)
424.01
477.55
10 %
Injection preparation: Urofollitropinum 150 UI
IBSA Institut
Biochimique SA
A / SL
FB
G
IP
CI
Fostimon 75 U.I.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 75 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 75 U.I.
10 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 75 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 150 U.I.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 150 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 150 U.I.
10 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 150 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 225 U.I.
Durchstechflasche(n)
63.19
88.95
k.A.
Injection preparation: Urofollitropinum 225 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
Fostimon 225 U.I.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 225 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 225 U.I.
5 Durchstechflasche(n)
252.76
306.55
k.A.
Injection preparation: Urofollitropinum 225 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
Fostimon 225 U.I.
5 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 225 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 300 U.I.
Durchstechflasche(n)
78.99
107.10
k.A.
Injection preparation: Urofollitropinum 300 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
Fostimon 300 U.I.
Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 300 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
CI
Fostimon 300 U.I.
5 Durchstechflasche(n)
315.96
379.10
k.A.
Injection preparation: Urofollitropinum 300 UI
IBSA Institut
Biochimique SA
A
FB
G
IP
Fostimon 300 U.I.
5 Durchstechflasche(n)
PR
PR
k.A.
Injection preparation: Urofollitropinum 300 UI
IBSA Institut
Biochimique SA
A
FB
G
Follitropin Alfa (G03GA05) 16 products
WHO-DDD
DrugBank.ca
L
IP
CI
Gonal-f PEN 300 U.I./0.48 ml
Set(s)
105.75
130.60
10 %
Injection solution: Follitropinum Alfa 300U.I. / 0.48ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
CI
Gonal-f PEN 450 U.I./0.72 ml
Set(s)
158.68
187.70
10 %
Injection solution: Follitropinum Alfa 450U.I. / 0.72ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
CI
Gonal-f PEN 900 U.I./1.44 ml
Set(s)
312.94
354.25
10 %
Injection solution: Follitropinum Alfa 900U.I. / 1.44ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
CI
Ovaleap 300 IU/0.5 ml
92.05
116.55
10 %
Injection solution: Follitropinum Alfa 300U.I. / 0.5ml
Labatec Pharma SA
A / SL
FB
G
L
IP
Ovaleap 450 IU/0.75 ml
138.12
166.65
10 %
Injection solution: Follitropinum Alfa 450U.I. / 0.75ml
Labatec Pharma SA
A / SL
FB
G
L
IP
Ovaleap 900 IU/1.5 ml
272.39
312.65
10 %
Injection solution: Follitropinum Alfa 900U.I. / 1.5ml
Labatec Pharma SA
A / SL
FB
G
IP
CI
Gonal-f 75 U.I.(5.5 µg)
Set(s)
30.54
49.65
k.A.
Injection preparation: Follitropinum Alfa 75 UI
Merck (Schweiz) AG
A
FB
G
IP
CI
Gonal-f 450 U.I./0.75 ml (33
µg/0.75 ml)
Set(s)
189.49
234.15
k.A.
Injection preparation: Follitropinum Alfa 450 UI
Merck (Schweiz) AG
A
FB
G
IP
CI
Gonal-f 1050 U.I./1.75 ml (77
µg/1.75 ml)
Set(s)
435.82
517.25
k.A.
Injection preparation: Follitropinum Alfa 1200 UI
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle Pen 300IE / 0.5 ml
Set(s)
PR
PR
k.A.
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle Pen 450IE / 0.75 ml
Set(s)
PR
PR
k.A.
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle Pen 900IE / 1.5 ml
Set(s)
PR
PR
k.A.
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle 75 U.I.(5.5 µg)
Set(s)
PR
PR
k.A.
Injection preparation: Follitropinum Alfa 75 UI
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle 75 U.I.(5.5 µg)
Set(s)
PR
PR
k.A.
Injection preparation: Follitropinum Alfa 75 UI
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle 450 U.I./0.75 mL (33
µg/0.75 mL)
Set(s)
PR
PR
k.A.
Injection preparation: Follitropinum Alfa 600 UI
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle 1050 U.I./1.75 mL (77
µg/1.75 mL)
Set(s)
PR
PR
k.A.
Injection preparation: Follitropinum Alfa 1200 UI
Merck (Schweiz) AG
A
FB
G
Follitropin Beta (G03GA06) 3 products
WHO-DDD
DrugBank.ca
L
IP
CI
Puregon 300 I.E.
Zylinderampulle(n)
75.00
98.00
10 %
Zylinderampullen für Pen: Follitropinum Beta 400U.I. / 0.48ml
Organon GmbH
A / SL
FB
G
L
IP
CI
Puregon 600 I.E.
Zylinderampulle(n)
150.00
179.55
10 %
Zylinderampullen für Pen: Follitropinum Beta 700U.I. / 0.84ml
Organon GmbH
A / SL
FB
G
L
IP
CI
Puregon 900 I.E.
Zylinderampulle(n)
225.00
261.10
10 %
Zylinderampullen für Pen: Follitropinum Beta 1025U.I. / 1.23ml
Organon GmbH
A / SL
FB
G
Lutropin Alfa (G03GA07) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Luveris 75 IE
Durchstechflasche(n)
40.70
60.70
10 %
Lyophilisate and solvent: Lutropinum Alfa 3.7 µg
Merck (Schweiz) AG
A / SL
FB
G
Choriogonadotropin Alfa (G03GA08) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Ovitrelle 250 µg
syringe(s)
30.74
49.85
10 %
Injection solution in prefilled syringe: Choriogonadotropinum Alfa 250µg / 0.5ml
Merck (Schweiz) AG
A / SL
FB
G
Follitropin Delta (G03GA10) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Rekovelle Pen 12 µg/0.36 ml
PR
PR
k.A.
Injection solution: Follitropinum Delta 12µg / 0.36ml
Ferring AG
A
FB
G
IP
Rekovelle Pen 36 µg/1.08 ml
PR
PR
k.A.
Injection solution: Follitropinum Delta 36µg / 1.08ml
Ferring AG
A
FB
G
IP
Rekovelle Pen 72 µg/2.16 ml
PR
PR
k.A.
Injection solution: Follitropinum Delta 72µg / 2.16ml
Ferring AG
A
FB
G
Combinations (G03GA30) 3 products
WHO-DDD
DrugBank.ca
L
IP
CI
Pergoveris Pen 300 IE/150
IE/0.48 ml
160.59
191.05
10 %
Injection solution: 2 Active Agents
Merck (Schweiz) AG
A / SL
FB
G
L
IP
Pergoveris Pen 450 IE/225
IE/0.72 ml
240.89
278.40
10 %
Injection solution: 2 Active Agents
Merck (Schweiz) AG
A / SL
FB
G
L
IP
Pergoveris Pen 900 IE/450
IE/1.44 ml
481.77
540.35
10 %
Injection solution: 2 Active Agents
Merck (Schweiz) AG
A / SL
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home